发现一种对闭膜原酶具有高选择性的强制性抑制剂
Esther Schönauer1, Andreas M Kany2, Jörg Haupenthal2
1Division of Structural Biology, Department of Molecular Biology, University of Salzburg , Billrothstrasse 11, 5020 Salzburg, Austria.
Journal of the American Chemical Society
|August 19, 2017
概括
研究人员开发了针对细菌原酶的新型抑制剂, 这些化合物具有很高的选择性,可以节省人体基质金属蛋白酶 (MMP),为抗微生物感染提供有前途的治疗策略.
科学领域:
- 生物化学
- 微生物学
- 药物发现
背景情况:
- 细菌原酶是微生物感染的关键毒性因素.
- 之前的抑制剂缺乏选择性,抑制人类基质金属蛋白酶 (MMPs).
研究的目的:
- 为了发现细菌原酶的选择性抑制剂.
- 开发抗微生物感染的潜在治疗药物.
主要方法:
- 基于表面等离子体共振的选.
- 酶抑制试验
- 抑制剂-目标复合物的晶体结构分析.
主要成果:
- 对Clostridium histolyticum H原酶 (ColH) 具有亚微分子亲和度的已识别的N- 甲胺抑制剂.
- 抑制剂有效地阻断同类细菌原酶 (ColG,ColT,ColQ1).
- 对人类MMP的活性可忽略不计,具有1000倍以上的选择性.
- 晶体结构显示出一个独特的无结合模式.
结论:
- 发现了一种选择性细菌原酶抑制剂的新型支架.
- 非预制结合模式为开发广泛的抗菌剂提供了一种策略.
- 这些发现为新的抗微生物感染疗法铺平了道路.
相关概念视频
Enzyme Inhibition
72.4K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
72.4K
Enzymes
68.9K
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
68.9K
Drug-Receptor Bonds
4.8K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
4.8K
Dose-Response Relationship: Selectivity and Specificity
10.2K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
10.2K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
1.1K
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
1.1K
Indirect-Acting Cholinergic Agonists: Mechanism of Action
2.8K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.8K


